PGIM India Healthcare Fund Regular IDCW
Summary Info
Fund Name
: PGIM India Mutual Fund
Scheme Name
: PGIM India Healthcare Fund Regular IDCW
AMC
: PGIM India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 19-Nov-2024
Fund Manager
: Anandha Padmanabhan Anjen
Net Assets (Rs. cr)
: 85.19
PGIM India Healthcare Fund Regular IDCW - Nav Details
Nav Date
: 13-Apr-2026
NAV [Rs.]
: 9.7
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL
PGIM India Healthcare Fund Regular IDCW- NAV Chart
PGIM India Healthcare Fund Regular IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 3.38 | -2.88 | 0.2 | -1.31 | 8.08 | - | - | -1.79 |
| Category Avg | 3.41 | -1.83 | -1.62 | -3.48 | 9.25 | 22.9 | 14.11 | 12.36 |
| Category Best | 5.84 | 2.79 | 2.55 | 2.07 | 17.86 | 26.87 | 16.87 | 26.4 |
| Category Worst | 2.41 | -3.33 | -6.22 | -7.32 | 2.48 | 18.66 | 10.34 | -7.69 |
PGIM India Healthcare Fund Regular IDCW- Latest Dividends
No Records Found
PGIM India Healthcare Fund Regular IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Pfizer1,705
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.41 | 60188 | 10.57 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 10.01 | 14339 | 8.52 |
| Equity | Aster DM Health. | Healthcare Services | 7.51 | 95489 | 6.39 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 6.98 | 28785 | 5.94 |
| Equity | Max Healthcare | Healthcare Services | 5.56 | 49201 | 4.73 |
| Equity | Rubicon Research | Pharmaceuticals & Biotechnology | 5.44 | 59960 | 4.63 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 5.02 | 15260 | 4.28 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 4.96 | 21045 | 4.22 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 3.95 | 26781 | 3.36 |
| Equity | Krishna Institu. | Healthcare Services | 3.81 | 52247 | 3.24 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.16 | 1038 | 2.69 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 3.00 | 4152 | 2.55 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.99 | 19420 | 2.54 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 2.85 | 5760 | 2.43 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 2.50 | 1774 | 2.13 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.48 | 21756 | 2.11 |
| Equity | Jupiter Life Lin | Healthcare Services | 2.25 | 14990 | 1.92 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 2.12 | 27457 | 1.80 |
| Equity | Global Health | Healthcare Services | 1.64 | 14551 | 1.39 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 1.60 | 11122 | 1.36 |
| Equity | PB Fintech. | Financial Technology (Fintech) | 1.29 | 7678 | 1.09 |
| Equity | ICICI Lombard | Insurance | 1.23 | 6118 | 1.04 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 1.00 | 20940 | 0.85 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 0.93 | 1705 | 0.80 |
| Equity | Lenskart Solut. | Retailing | 0.79 | 13501 | 0.67 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.58 | 10285 | 0.49 |
| Equity | Sagility | IT - Services | 0.58 | 122624 | 0.48 |
| Equity | Dr Agarwal's Eye | Healthcare Services | 0.55 | 994 | 0.46 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
26,401.18
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Mr.Muralidharan Rajamani, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere
OTHER INFORMATION
Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Email:
Website:
